1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ashani Weeraratna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A framework for advancing our understanding of cancer-associated fibroblasts

Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., Hynes, R. O., Jain, R. K., Janowitz, T., Jorgensen, C., Kimmelman, A. C., Kolonin, M. G., Maki, R. G., Powers, R. S., Puré, E., Ramirez, D. C. & 9 others, Scherz-Shouval, R., Sherman, M. H., Stewart, S., Tlsty, T. D., Tuveson, D. A., Watt, F. M., Weaver, V., Weeraratna, A. T. & Werb, Z., Mar 1 2020, In : Nature Reviews Cancer. 20, 3, p. 174-186 13 p.

Research output: Contribution to journalReview article

Open Access
  • Erratum: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))

    Webster, M. R., Fane, M. E., Alicea, G. M., Basu, S., Kossenkov, A. V., Marino, G. E., Douglass, S. M., Kaur, A., Ecker, B. L., Gnanapradeepan, K., Ndoye, A., Kugel, C., Valiga, A., Palmer, J., Liu, Q., Xu, X., Morris, J., Yin, X., Wu, H., Xu, W. & 12 others, Zheng, C., Karakousis, G. C., Amaravadi, R. K., Mitchell, T. C., Almeida, F. V., Xiao, M., Rebecca, V. W., Wang, Y. J., Schuchter, L. M., Herlyn, M., Murphy, M. E. & Weeraratna, A. T., Feb 6 2020, In : Molecular cell. 77, 3, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • How the ageing microenvironment influences tumour progression

    Fane, M. & Weeraratna, A. T., Feb 1 2020, In : Nature Reviews Cancer. 20, 2, p. 89-106 18 p.

    Research output: Contribution to journalReview article

  • Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma

    Webster, M. R., Fane, M. E., Alicea, G. M., Basu, S., Kossenkov, A. V., Marino, G. E., Douglass, S. M., Kaur, A., Ecker, B. L., Gnanapradeepan, K., Ndoye, A., Kugel, C., Valiga, A., Palmer, J., Liu, Q., Xu, X., Morris, J., Yin, X., Wu, H., Xu, W. & 12 others, Zheng, C., Karakousis, G. C., Amaravadi, R. K., Mitchell, T. C., Almeida, F. V., Xiao, M., Rebecca, V. W., Wang, Y. J., Schuchter, L. M., Herlyn, M., Murphy, M. E. & Weeraratna, A. T., Feb 6 2020, In : Molecular cell. 77, 3, p. 633-644.e5

    Research output: Contribution to journalArticle

  • Preserve junior faculty in biomedical sciences during and after the pandemic

    Avasthi, P., Neill, U. S., Pollack Porter, K. M. & Weeraratna, A. T., Jul 1 2020, In : Nature medicine. 26, 7, p. 1003-1004 2 p.

    Research output: Contribution to journalComment/debate

    Open Access